NCT00960791View on ClinicalTrials.gov

Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions

Type II Diabetes Mellitus

Interventions

DEVICE

AZD1656

Oral single dose

Trial Locations (2)

Unknown

Research Site, San Diego

Research Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY